Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
40.1 /100
Rank 13 out of 27 Sectors -
Advance/Decline
165/54
-
No. of Companies219
-
Avg. Market Cap9,762
-
Price to Earning Ratio34.37
-
Price to Earning Growth Ratio13.40
-
Price to Book Ratio38.43
-
Return on Equity36.12
-
Return on Capital Employed-
-
Return on Assets5.29
-
Dividend yield 1 year %0.19 %
-
Net Profit Growth Annual YoY %-1.58 %
-
Net Profit Growth Qtr YoY %22.94 %
-
Net Profit Growth Qtr QoQ %-0.49 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
43,892.7
|
155.4
|
L
 4.7%
H
150
156.3
|
L
 4.0%
H
146.8
156.3
|
L
 18.2%
H
125
156.3
|
L
 38.6%
H
108.4
156.3
|
L
 31.5%
H
108.4
160.3
|
L
 30.3%
H
96.4
160.3
|
L
 -4.7%
H
96.4
179.6
|
L
 232.6%
H
42.9
179.6
|
| Amerisource Bergen Corp |
|
-
|
317.1
|
L
 0.3%
H
312.0
322.5
|
L
 -5.0%
H
302.0
323.6
|
L
 3.0%
H
298.4
334.0
|
L
 21.1%
H
261.3
334.0
|
L
 9.2%
H
244.8
377.5
|
L
 75.8%
H
174.2
377.5
|
L
 167.4%
H
113.7
377.5
|
L
 256.4%
H
68.4
377.5
|
| Abbott |
|
198,007.8
|
114.4
|
L
 1.6%
H
112.9
115.7
|
L
 4.3%
H
107.5
115.7
|
L
 13.7%
H
99.3
115.7
|
L
 30.2%
H
85.0
115.7
|
L
 -12.2%
H
82.0
137.5
|
L
 10.3%
H
82.0
141.2
|
L
 -7.7%
H
82.0
142.6
|
L
 158.0%
H
37.4
142.6
|
| Alcon Inc - Registered Shares |
|
35,897.3
|
74.3
|
L
 1.0%
H
73.4
74.8
|
L
 -1.5%
H
72.1
74.9
|
L
 5.7%
H
66.2
76.2
|
L
 12.6%
H
63.8
76.2
|
L
 -15.7%
H
61.8
90.4
|
L
 -10.2%
H
61.8
101.1
|
L
 -7.2%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,405.2
|
28.8
|
L
 -0.3%
H
28.8
30.1
|
L
 1.5%
H
27.7
30.1
|
L
 15%
H
24.6
30.1
|
L
 21.3%
H
19.8
30.1
|
L
 -32.7%
H
19.2
48.3
|
L
 79.5%
H
12.2
48.3
|
L
 14.7%
H
9.6
48.3
|
L
 84.7%
H
9.6
48.3
|
| Avantor Inc |
|
9,442.0
|
14.0
|
L
 4.7%
H
13.5
14.1
|
L
 1.4%
H
13.3
14.1
|
L
 26.1%
H
10.2
14.6
|
L
 83.7%
H
7.4
14.6
|
L
 9.4%
H
7.3
15.9
|
L
 -34.9%
H
7.3
28
|
L
 -63.6%
H
7.3
44.4
|
L
H
6.7
44.4
|
| Baxter International |
|
13,772.8
|
26.6
|
L
 2.7%
H
25.9
26.8
|
L
 -3.5%
H
25.8
27.5
|
L
 17.8%
H
21.4
30
|
L
 49.8%
H
17.6
30
|
L
 12.8%
H
15.7
30
|
L
 -36.3%
H
15.7
44
|
L
 -64.6%
H
15.7
89.7
|
L
 -44.5%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
51,099.8
|
187.6
|
L
 3.8%
H
181.5
188.0
|
L
 3.4%
H
177.1
188.0
|
L
 18.6%
H
152.0
188.0
|
L
 31.8%
H
140.1
188.0
|
L
 -3.8%
H
140.1
213.1
|
L
 -31.5%
H
140.1
283.5
|
L
 -22.6%
H
140.1
287.3
|
L
 10.7%
H
140.1
287.3
|
| Butterfly Network Inc (Class A) |
|
2,441.8
|
9.2
|
L
 1.9%
H
9.0
9.5
|
L
 -2.1%
H
8.4
9.7
|
L
 38.5%
H
6.4
10.1
|
L
 138.8%
H
3.8
10.1
|
L
 536.8%
H
1.3
10.1
|
L
 406.6%
H
0.7
10.1
|
L
 -11.1%
H
0.7
13.6
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
9,739.6
|
364.3
|
L
 3.3%
H
352.7
368.0
|
L
 2.3%
H
351
368.0
|
L
 19.7%
H
285.4
368.0
|
L
 29.3%
H
270
368.0
|
L
 28.0%
H
236.7
368.0
|
L
 -4.3%
H
211.4
406.4
|
L
 -52.7%
H
211.4
832.7
|
L
 136.8%
H
147.7
832.7
|
| Bausch + Lomb Corp |
|
6,232.5
|
17.5
|
L
 2.4%
H
17.3
17.8
|
L
 3.4%
H
16.3
17.8
|
L
 7.3%
H
15.6
17.8
|
L
 8.3%
H
14.7
17.8
|
L
 20.7%
H
13.8
18.9
|
L
 -9.3%
H
10.5
21.7
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
75,374.4
|
52.0
|
L
 3.1%
H
50.7
52.6
|
L
 1.6%
H
50.0
53.0
|
L
 18.1%
H
42.5
53.0
|
L
 -7.0%
H
42.2
58.5
|
L
 -49.5%
H
42.2
109.5
|
L
 3.6%
H
42.2
109.5
|
L
 18.0%
H
35.0
109.5
|
L
 117.1%
H
19.7
109.5
|
| Cardinal Health |
|
54,620.4
|
234.9
|
L
 -0.1%
H
232.3
238.2
|
L
 -2.3%
H
229.3
239.8
|
L
 2.8%
H
220.4
258.3
|
L
 17.6%
H
194
258.3
|
L
 56.9%
H
145.9
258.3
|
L
 173.6%
H
85.1
258.3
|
L
 355.8%
H
45.9
258.3
|
L
 184.9%
H
39.1
258.3
|
| Conmed Corp |
|
1,535.0
|
51.3
|
L
 4.0%
H
50.0
52.2
|
L
 3.4%
H
48.4
52.2
|
L
 18.6%
H
41.0
53.7
|
L
 40.0%
H
31.4
53.7
|
L
 -4.0%
H
31.4
56.6
|
L
 -51.2%
H
31.4
117.3
|
L
 -59.1%
H
31.4
159.1
|
L
 28.0%
H
31.4
159.1
|
| Cooper Companies |
|
14,964.7
|
76.7
|
L
 1.3%
H
75.8
78.1
|
L
 -0.1%
H
75.0
78.1
|
L
 7%
H
69.6
78.1
|
L
 25.9%
H
59.1
78.1
|
L
 4.4%
H
58.9
89.8
|
L
 -16.8%
H
58.9
112.4
|
L
 -29.1%
H
58.9
115.9
|
L
 69.2%
H
39.7
115.9
|
| Danaher |
|
148,681.5
|
211.5
|
L
 6.0%
H
202.9
212.2
|
L
 2.0%
H
199.5
212.2
|
L
 3.8%
H
165.8
212.2
|
L
 29.1%
H
164.1
212.2
|
L
 1.2%
H
160.9
242.8
|
L
 -15.9%
H
160.9
281.7
|
L
 -32.9%
H
160.9
334.0
|
L
 162.5%
H
75.7
334.0
|
| Enovis Corp |
|
1,528.2
|
26.5
|
L
 3.4%
H
25.7
27.5
|
L
 7.7%
H
23.6
27.5
|
L
 -2.1%
H
23.6
31.7
|
L
 5.0%
H
19.1
31.7
|
L
 -10.3%
H
19.1
34.3
|
L
 -51.8%
H
19.1
65.0
|
L
H
19.1
72.1
|
L
H
19.1
72.1
|
| Edwards Lifesciences |
|
53,190.2
|
92.3
|
L
 1.4%
H
91.3
93.3
|
L
 -1.5%
H
90.4
93.8
|
L
 7.6%
H
81.2
93.9
|
L
 12%
H
80.9
96.3
|
L
 17.9%
H
72.3
96.3
|
L
 20.5%
H
58.9
96.3
|
L
 -20.6%
H
58.9
131.7
|
L
 140.8%
H
27.0
131.7
|
| Glaukos Corp |
|
11,180.4
|
189.6
|
L
 2.9%
H
186.0
190.1
|
L
 4.2%
H
175.0
190.1
|
L
 20.9%
H
145.8
190.1
|
L
 33.3%
H
99.5
190.1
|
L
 111.7%
H
73.2
190.1
|
L
 164.0%
H
59.2
190.1
|
L
 297.0%
H
33.3
190.1
|
L
 499.1%
H
23.1
190.1
|
| Globus Medical Inc (Class A) |
|
11,860.7
|
88.3
|
L
 2.2%
H
87.0
88.9
|
L
 3.8%
H
83.2
88.9
|
L
 14.7%
H
74.5
88.9
|
L
 11.9%
H
74.4
88.9
|
L
 46.6%
H
54.2
101.4
|
L
 60.6%
H
43.4
101.4
|
L
 15.0%
H
43.4
101.4
|
L
 290.2%
H
19.3
101.4
|
| Haemonetics Corp |
|
4,932.3
|
108.4
|
L
 3.6%
H
105.0
108.5
|
L
 24.3%
H
86.1
108.5
|
L
 39.2%
H
75.0
108.5
|
L
 89.3%
H
55.8
108.5
|
L
 104.1%
H
47.3
108.5
|
L
 27.6%
H
47.3
108.5
|
L
 84.9%
H
43.5
108.5
|
L
 203.6%
H
32.8
142.1
|
| Inspire Medical Systems Inc |
|
1,783.5
|
61.7
|
L
 7.5%
H
57.8
62.0
|
L
 4.3%
H
55.4
62.0
|
L
 21.9%
H
48.2
66.2
|
L
 47.5%
H
38.9
66.2
|
L
 -30.2%
H
38.9
147.0
|
L
 -71.5%
H
38.9
257.4
|
L
 -70.2%
H
38.9
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
4,259.2
|
125.3
|
L
 0.2%
H
125.1
125.4
|
L
 0.2%
H
125
125.4
|
L
 31.3%
H
94.9
126.1
|
L
 39.3%
H
87.0
126.1
|
L
 18.7%
H
62
126.1
|
L
 49.5%
H
62
146.4
|
L
 28.6%
H
50.1
146.4
|
L
 461.6%
H
18.1
146.4
|
| McKesson |
|
99,534.4
|
853.7
|
L
 -1.8%
H
850.0
870.0
|
L
 -5.3%
H
850.0
902.0
|
L
 1.5%
H
808.6
912.5
|
L
 10.0%
H
729.2
912.5
|
L
 27.2%
H
667.5
999
|
L
 103.1%
H
404.7
999
|
L
 327.5%
H
193.9
999
|
L
 339.1%
H
106.1
999
|
| Medtronic |
|
120,484.6
|
94.1
|
L
 2.2%
H
92.0
94.7
|
L
 3.8%
H
88.5
94.7
|
L
 13.1%
H
81.5
94.7
|
L
 21.7%
H
73.3
94.7
|
L
 1.4%
H
73.3
106.3
|
L
 15.5%
H
68.9
106.3
|
L
 -27.2%
H
68.9
135.9
|
L
 8.1%
H
68.9
135.9
|
| Mettler-Toledo International |
|
28,553.9
|
1,425.1
|
L
 1.8%
H
1419.4
1456.8
|
L
 -0.8%
H
1396.1
1456.8
|
L
 8.8%
H
1216.9
1474.2
|
L
 32.6%
H
1027.7
1474.2
|
L
 8.7%
H
1023.1
1525.2
|
L
 20.3%
H
928.5
1546.9
|
L
 -6.2%
H
928.5
1714.8
|
L
 251.4%
H
386.0
1714.8
|
| Envista Holdings Corp |
|
4,429.8
|
27.6
|
L
 -0.9%
H
27.5
28.9
|
L
 -3.3%
H
27.3
29
|
L
 3.1%
H
25.8
29
|
L
 19.1%
H
22.4
29
|
L
 32.8%
H
18.8
30.4
|
L
 -15.6%
H
14.2
33.3
|
L
 -31.6%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
101.5
|
1.3
|
L
 16.8%
H
1.1
1.3
|
L
 4.8%
H
0.9
1.4
|
L
 -62.0%
H
0.9
3.6
|
L
 -51.8%
H
0.9
3.8
|
L
 -75.8%
H
0.9
5.7
|
L
 -91.9%
H
0.9
28.4
|
L
 -96.5%
H
0.9
49.1
|
L
 -96.1%
H
0.9
49.2
|
| Penumbra Inc |
|
12,874.0
|
326.8
|
L
 0.6%
H
325.5
327.8
|
L
 0.2%
H
324.8
328.6
|
L
 2.7%
H
315.7
328.6
|
L
 0.1%
H
314.8
329.7
|
L
 28%
H
221.3
362.4
|
L
 30.1%
H
148
362.4
|
L
 28.5%
H
114.9
362.4
|
L
 340.7%
H
56.1
362.4
|
| Perkinelmer Inc |
|
-
|
119.5
|
L
 5.0%
H
115.3
122.1
|
L
 3.2%
H
113.7
122.1
|
L
 8.4%
H
102.4
122.1
|
L
 25.1%
H
93.0
122.1
|
L
 33.2%
H
81.2
122.1
|
L
 28.1%
H
81.2
122.1
|
L
 -34.0%
H
81.2
201.1
|
L
 117.3%
H
45.4
201.1
|
| Qiagen NV |
|
9,189.0
|
44.5
|
L
 5.2%
H
43.4
44.8
|
L
 4.3%
H
42.1
44.8
|
L
 8.1%
H
39.4
44.8
|
L
 31.7%
H
33.8
44.8
|
L
 -13.1%
H
32.5
57.8
|
L
 -7.4%
H
32.5
57.8
|
L
 -24.2%
H
32.5
64.7
|
L
 39.0%
H
27.8
65.9
|
| ResMed |
|
33,271.8
|
230.7
|
L
 4.9%
H
220.4
231.0
|
L
 2.6%
H
218.7
231.0
|
L
 15.9%
H
190.2
231.0
|
L
 13.0%
H
180.3
231.0
|
L
 -19.4%
H
180.3
293.8
|
L
 39.2%
H
132.2
293.8
|
L
 -17.5%
H
132.2
301.3
|
L
 231.5%
H
56.6
301.3
|
| Silvergate Cap Corp (Class A) |
|
484.2
|
23.3
|
L
 10.1%
H
20.7
23.3
|
L
 18.5%
H
18.7
23.3
|
L
 7.7%
H
18.7
24.6
|
L
 57.4%
H
13.5
24.6
|
L
 62.3%
H
10.9
24.6
|
L
 55.1%
H
10.9
24.6
|
L
 -76.1%
H
0.0
239.3
|
L
 17.8%
H
0.0
239.3
|
| Steris PLC |
|
23,098.8
|
236.9
|
L
 2.0%
H
233.8
238.7
|
L
 -0.6%
H
229.4
238.7
|
L
 8.8%
H
208.5
241.4
|
L
 11.3%
H
198.0
241.4
|
L
 -3.1%
H
195.1
269.4
|
L
 5.8%
H
195.1
269.4
|
L
 9.5%
H
159.2
269.4
|
L
 233.7%
H
63.8
269.4
|
| Stevanato Grp Spa |
|
5,929.6
|
21.7
|
L
 2.4%
H
21.3
21.8
|
L
 3.1%
H
20.6
21.8
|
L
 13.3%
H
18.8
21.8
|
L
 22.0%
H
16.3
21.8
|
L
 -3.9%
H
12.9
28
|
L
 -29.9%
H
12.9
35.6
|
L
 7.6%
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
130,407.2
|
340.0
|
L
 2.6%
H
331
343.9
|
L
 -2.4%
H
331
347.5
|
L
 6.3%
H
306.9
352.5
|
L
 8.5%
H
291.0
352.5
|
L
 -10.9%
H
281
396.9
|
L
 22.3%
H
250.0
406.2
|
L
 29.0%
H
188.8
406.2
|
L
 198.9%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
12,266.4
|
29.3
|
L
 -2.9%
H
29.2
29.9
|
L
 -2.3%
H
29.2
30.4
|
L
 -4.2%
H
29.2
32.9
|
L
 -3.3%
H
28.6
32.9
|
L
 -19.2%
H
28.6
38.8
|
L
 7.8%
H
21.5
38.8
|
L
 -23.2%
H
21.5
39.2
|
L
 -12.7%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,756.7
|
135.9
|
L
 3.0%
H
132.6
136.8
|
L
 1.7%
H
130.9
138
|
L
 0.9%
H
130.0
145
|
L
 4.2%
H
120.9
145
|
L
 13.4%
H
100.2
145
|
L
 -37.6%
H
100.2
257.9
|
L
 -63.5%
H
100.2
405.9
|
L
 -26.1%
H
100.2
449.4
|
| Thermo Fisher |
|
226,854.8
|
613.5
|
L
 4.2%
H
595
620.5
|
L
 1.4%
H
580
620.5
|
L
 15.2%
H
495.0
620.5
|
L
 38.8%
H
438.7
620.5
|
L
 25.8%
H
435.3
644.0
|
L
 15.2%
H
385.5
644.0
|
L
 12.6%
H
385.5
672.3
|
L
 300.1%
H
139.1
672.3
|
| Waters |
|
40,855.5
|
415.8
|
L
 3.6%
H
404.2
419.4
|
L
 0.2%
H
400.9
420.3
|
L
 12.7%
H
345.2
420.3
|
L
 25.2%
H
323.9
420.3
|
L
 43.7%
H
282.8
420.3
|
L
 54.0%
H
231.9
423.6
|
L
 3.8%
H
231.9
428.2
|
L
 161.4%
H
133.4
428.2
|
| West Pharma Services |
|
24,827.9
|
352.8
|
L
 1.8%
H
348.3
356.4
|
L
 0.4%
H
343.5
356.4
|
L
 -1.5%
H
325.3
386
|
L
 15.9%
H
299.7
386
|
L
 45.1%
H
223.8
386
|
L
 -9.0%
H
187.4
415.7
|
L
 -20.2%
H
187.4
475.4
|
L
 334.8%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
19,214.9
|
100.7
|
L
 1.6%
H
98.1
102.0
|
L
 3.6%
H
94.3
102.0
|
L
 10.6%
H
87.9
102.0
|
L
 18.3%
H
81.6
102.0
|
L
 -1.8%
H
79.1
108.3
|
L
 -15.5%
H
79.1
133.9
|
L
 -25.9%
H
79.1
149.3
|
L
 -16.4%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
9,701.9
|
337
|
L
H
337
337
|
L
H
337
337
|
L
 8.9%
H
337
337
|
L
 26.0%
H
289.2
337
|
L
 36.4%
H
244.5
337
|
L
 1.4%
H
225.3
373.4
|
L
 1.4%
H
225.3
373.4
|
L
 1.4%
H
225.3
373.4
|
| Revvity |
|
13,329.0
|
119.5
|
L
 5.0%
H
115.3
122.1
|
L
 3.2%
H
113.7
122.1
|
L
 8.4%
H
102.4
122.1
|
L
 25.1%
H
93.0
122.1
|
L
 33.2%
H
81.2
122.1
|
L
 5.5%
H
79.5
129.5
|
L
 -34.0%
H
79.5
203.2
|
L
 117.3%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
1.1
|
2.8
|
L
 -3.8%
H
2.7
3.0
|
L
 -12.6%
H
2.7
3.1
|
L
 327.7%
H
0.5
3.8
|
L
 36.3%
H
0.5
3.8
|
L
 -76.2%
H
0.5
27.4
|
L
 -98.8%
H
0.5
256
|
L
 -99.9%
H
0.5
4791.9
|
L
 -100.0%
H
0.5
69290.4
|
| Airsculpt Tech Inc |
|
202.6
|
2.8
|
L
 4.1%
H
2.6
2.9
|
L
 -12.7%
H
2.6
3.5
|
L
 -36.9%
H
2.5
5.2
|
L
 -41.0%
H
2.5
5.8
|
L
 -55.5%
H
1.5
12
|
L
 -64.1%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
11,582.3
|
163.0
|
L
 -2.9%
H
162.6
173.7
|
L
 -5.7%
H
162.6
182.2
|
L
 -7.8%
H
162.6
188.0
|
L
 2.7%
H
151.6
191.0
|
L
 12.5%
H
122
200.4
|
L
 -53.5%
H
122
375.7
|
L
 -75.9%
H
122
737.5
|
L
 72.1%
H
83.3
737.5
|
| Angiodynamic Inc |
|
664.2
|
16.1
|
L
 1.6%
H
15.8
16.3
|
L
 2.0%
H
15.2
16.3
|
L
 19.0%
H
13.2
16.3
|
L
 45.2%
H
10.7
16.3
|
L
 83.0%
H
8.7
16.3
|
L
 86.6%
H
5.3
16.3
|
L
 -40.4%
H
5.3
32
|
L
H
5.3
32
|
| Anika Therapeutics Inc |
|
284.5
|
21.3
|
L
 -1.4%
H
21.3
22.1
|
L
 0.1%
H
20.4
22.4
|
L
 39.4%
H
14.6
22.9
|
L
 42.2%
H
13.8
22.9
|
L
 144.7%
H
8.2
22.9
|
L
 13.0%
H
7.9
29.1
|
L
 -48.9%
H
7.9
45.8
|
L
 -57.3%
H
7.9
75.7
|
| Anzu Special Acq Corp I (Class A) |
|
-
|
0.7
|
L
H
0.7
0.8
|
L
 -3.9%
H
0.7
0.8
|
L
 5.7%
H
0.6
0.8
|
L
 4.2%
H
0.6
0.9
|
L
 -45.2%
H
0.4
1.9
|
L
 -92.9%
H
0.4
11.7
|
L
 -92.4%
H
0.4
11.7
|
L
H
0.4
11.7
|
| Apyx Medical Corp |
|
132.7
|
3.2
|
L
 1.3%
H
3.1
3.3
|
L
 4.3%
H
2.9
3.3
|
L
 -26.4%
H
2.9
4.4
|
L
 -18.6%
H
2.9
5.1
|
L
 47.2%
H
1.7
5.1
|
L
 -31.8%
H
0.8
5.1
|
L
 -69.4%
H
0.8
17.5
|
L
 -15.1%
H
0.8
17.5
|
| Accuray Inc |
|
35.8
|
0.3
|
L
 -6.3%
H
0.3
0.3
|
L
 3.5%
H
0.3
0.3
|
L
 15.4%
H
0.2
0.3
|
L
 3.5%
H
0.2
0.4
|
L
 -81.5%
H
0.2
2.1
|
L
 -89.7%
H
0.2
3.1
|
L
 -91.5%
H
0.2
5.9
|
L
 -94%
H
0.2
6.4
|
| Alphatec Holdings Inc |
|
1,505.9
|
9.8
|
L
 2.3%
H
9.5
10
|
L
 4.1%
H
9.1
10
|
L
 14.2%
H
8.0
10.4
|
L
 20.5%
H
7.3
10.4
|
L
 -38.5%
H
6.8
23.3
|
L
 -32.3%
H
4.9
23.3
|
L
 -21.1%
H
4.9
23.3
|
L
 162.1%
H
1.2
23.3
|
| Atricure Inc |
|
2,421.7
|
47.6
|
L
 4.0%
H
46.3
48.0
|
L
 10.9%
H
41.9
48.0
|
L
 36.2%
H
31.9
48.0
|
L
 67.2%
H
25.4
48.0
|
L
 33.7%
H
25.4
48.0
|
L
 2.2%
H
18.9
48.6
|
L
 -34.8%
H
18.9
89.2
|
L
 226.8%
H
14.4
89.2
|
| Axogen Inc |
|
2,630.6
|
48.9
|
L
 -2.5%
H
48.9
50.6
|
L
 0.9%
H
47.3
50.7
|
L
 22.8%
H
38.3
50.7
|
L
 16.6%
H
38.1
50.7
|
L
 215.9%
H
13.6
50.7
|
L
 751.0%
H
3.5
50.7
|
L
 221.3%
H
3.5
50.7
|
L
 445.5%
H
3.5
56.9
|
| Bone Biologics Corp |
|
1.1
|
0.6
|
L
H
0.6
0.6
|
L
 -29.7%
H
0.6
0.7
|
L
 -45.3%
H
0.6
1.2
|
L
 -48.8%
H
0.6
1.5
|
L
 -69.2%
H
0.6
4.1
|
L
 -98.2%
H
0.6
63.4
|
L
 -100.0%
H
0.6
10255.5
|
L
 -100.0%
H
0.6
169920
|
| BioAffinity Tech Inc |
|
3.3
|
0.4
|
L
 -12.8%
H
0.4
0.5
|
L
 -16.3%
H
0.3
0.6
|
L
 -41.4%
H
0.3
0.7
|
L
 -75.6%
H
0.3
2.2
|
L
 -94.4%
H
0.3
13.5
|
L
 -99.2%
H
0.3
108.6
|
L
H
0.3
466.5
|
L
H
0.3
466.5
|
| Bluejay Diagnostics Inc |
|
1.0
|
1.0
|
L
 -1.0%
H
0.9
1.0
|
L
 -10.3%
H
0.9
1.1
|
L
 -33.8%
H
0.8
1.7
|
L
 -44.2%
H
0.8
7
|
L
 -82.7%
H
0.8
16.7
|
L
 -100.0%
H
0.8
13120
|
L
H
0.8
200000
|
L
H
0.8
200000
|
| Biolife Soln Inc |
|
1,783.6
|
36.5
|
L
 4.4%
H
35.5
36.9
|
L
 4.7%
H
34.4
36.9
|
L
 25.1%
H
28.5
36.9
|
L
 63.5%
H
21.9
36.9
|
L
 48.9%
H
17.9
36.9
|
L
 237.4%
H
8.9
36.9
|
L
 -17.6%
H
8.9
60.7
|
L
 1871.4%
H
1.4
60.7
|
| Biomerica Inc |
|
4.7
|
1.5
|
L
 -5%
H
1.5
1.6
|
L
 -3.2%
H
1.5
1.7
|
L
 -5.6%
H
1.5
1.7
|
L
 -32.4%
H
1.5
2.5
|
L
 -50.5%
H
1.5
3.6
|
L
 28.8%
H
0.2
4.9
|
L
 -62.5%
H
0.2
7.4
|
L
 -51.6%
H
0.2
23.4
|
| Bruker Corp |
|
8,935.9
|
58.7
|
L
 3.2%
H
57.0
61.8
|
L
 2.9%
H
56.7
61.8
|
L
 0.7%
H
48.6
65.3
|
L
 37.2%
H
41.6
65.3
|
L
 71.3%
H
28.5
65.3
|
L
 -5.8%
H
28.5
94.9
|
L
 -29.3%
H
28.5
94.9
|
L
 167.2%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
5.4
|
0.2
|
L
H
0.2
0.2
|
L
H
0.2
0.2
|
L
 -36.4%
H
0.2
0.4
|
L
 10.5%
H
0.2
0.7
|
L
 -86.4%
H
0.2
1.9
|
L
 -91.1%
H
0.2
3.7
|
L
 -98.5%
H
0.2
26.8
|
L
 -100.0%
H
0.2
20040
|
| Bioventus Inc (Class A) |
|
1,234.5
|
14.7
|
L
 2.7%
H
14.4
14.9
|
L
 6.0%
H
13.5
14.9
|
L
 21.7%
H
11.4
15.9
|
L
 38.1%
H
7.8
15.9
|
L
 104.5%
H
6.3
15.9
|
L
 235.2%
H
2.8
15.9
|
L
 -2.5%
H
0.8
17.5
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
608.8
|
15.2
|
L
 3.5%
H
14.9
15.2
|
L
 1.3%
H
14.5
17.4
|
L
 -3.6%
H
14.1
17.4
|
L
 2.0%
H
13.8
17.4
|
L
 308.9%
H
3.6
17.4
|
L
 1796.3%
H
0.8
17.4
|
L
 622.4%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
5.9
|
2.0
|
L
 4.2%
H
1.9
2.0
|
L
 8.7%
H
1.8
2.3
|
L
 15.7%
H
1.4
2.3
|
L
 43.2%
H
1.3
2.6
|
L
 -46.5%
H
1.0
7.9
|
L
 -92.4%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
2,406.2
|
46.5
|
L
 0.7%
H
46.4
48.4
|
L
 -1.5%
H
44.8
48.4
|
L
 17.1%
H
35.0
49.8
|
L
 125.9%
H
20.0
49.8
|
L
 292.5%
H
11.3
49.8
|
L
 453.0%
H
4.8
49.8
|
L
 -34.4%
H
4.8
81.5
|
L
 845.3%
H
0.8
99.8
|
| Celcuity Inc |
|
4,582.5
|
93.7
|
L
 0.4%
H
91.9
96
|
L
 6.3%
H
83.0
96
|
L
 6.0%
H
78.6
96
|
L
 -29.2%
H
78.6
142.8
|
L
 81.6%
H
44.4
151.0
|
L
 923.5%
H
7.6
151.0
|
L
 372.0%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
7.4
|
1.1
|
L
 3.7%
H
1.1
1.2
|
L
 -9.7%
H
1.1
1.3
|
L
 27.3%
H
0.6
1.9
|
L
 -49.8%
H
0.6
4.7
|
L
 -66.0%
H
0.6
6.3
|
L
 -75.2%
H
0.6
10.3
|
L
 -99.1%
H
0.6
171.5
|
L
 -100.0%
H
0.6
525000
|
| Cerus Corp |
|
574.3
|
2.9
|
L
 3.3%
H
2.8
2.9
|
L
 11.3%
H
2.6
3.1
|
L
 -9.0%
H
2.1
3.2
|
L
 17.3%
H
2.1
3.5
|
L
 128%
H
1.2
3.5
|
L
 66.7%
H
1.1
3.5
|
L
 -51.2%
H
1.1
8.1
|
L
 -57.5%
H
1.1
8.9
|
| Check-Cap Ltd |
|
11.2
|
8.3
|
L
 -0.7%
H
8.2
8.5
|
L
 591.7%
H
1.2
10.2
|
L
 18.6%
H
1.2
10.5
|
L
 -36.6%
H
1.2
13.7
|
L
 79.3%
H
1.2
27.4
|
L
 -56.9%
H
1.2
32.4
|
L
 -93.7%
H
1.2
183.4
|
L
 -99.7%
H
1.2
4956
|
| Ridgetech Inc |
|
2.9
|
0.8
|
L
 -1.2%
H
0.8
0.8
|
L
 -12.0%
H
0.8
1.0
|
L
 -42.6%
H
0.7
1.8
|
L
 -41.3%
H
0.7
3.1
|
L
 -99.6%
H
0.7
760.5
|
L
 -99.9%
H
0.7
1047
|
L
 -100.0%
H
0.7
35370
|
L
 -100.0%
H
0.7
124560
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
6.1
|
0.3
|
L
 3.2%
H
0.3
0.3
|
L
 6.7%
H
0.3
0.3
|
L
 -5.9%
H
0.3
0.4
|
L
 -27.3%
H
0.3
0.5
|
L
 -88.0%
H
0.3
3.2
|
L
 -95.2%
H
0.3
7.9
|
L
 -98.2%
H
0.3
23
|
L
 -98.2%
H
0.3
24.3
|
| ClearPoint Neuro Inc |
|
486.8
|
16.0
|
L
 5.1%
H
15.4
16.1
|
L
 7.1%
H
14.5
16.1
|
L
 5.4%
H
12.3
16.1
|
L
 43.4%
H
10.9
19.6
|
L
 42.3%
H
8.3
30.1
|
L
 198.9%
H
4.1
30.1
|
L
 -9.3%
H
4.1
30.1
|
L
 118.6%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
70.0
|
0.9
|
L
 1.1%
H
0.9
0.9
|
L
 -14.3%
H
0.9
1.1
|
L
 2.3%
H
0.8
1.1
|
L
 -46.8%
H
0.8
2
|
L
 -63.0%
H
0.8
3.3
|
L
 -51.1%
H
0.8
6.4
|
L
 -84.0%
H
0.8
8.6
|
L
 -99.8%
H
0.7
409.0
|
| Castle Biosciences Inc |
|
987.4
|
32.3
|
L
 11.3%
H
29.0
32.4
|
L
 0.3%
H
28.7
33
|
L
 33.8%
H
23.3
33.1
|
L
 67.3%
H
18.8
33.1
|
L
 57.2%
H
17.7
44.3
|
L
 84.1%
H
12.1
44.3
|
L
 -47.3%
H
9.3
78.6
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
610.9
|
4.7
|
L
 0.6%
H
4.7
4.9
|
L
 -0.8%
H
4.6
4.9
|
L
 1.7%
H
4.0
4.9
|
L
 32.4%
H
3.5
4.9
|
L
 15.8%
H
3.3
6.2
|
L
 -44.4%
H
2.4
9.9
|
L
 -78.9%
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
22.6
|
0.4
|
L
H
0.4
0.4
|
L
H
0.4
0.4
|
L
H
0.4
0.4
|
L
 -25%
H
0.4
0.6
|
L
 -67.3%
H
0.4
1.1
|
L
 -86.5%
H
0.4
2.9
|
L
 -95.2%
H
0.4
9.8
|
L
 -92.8%
H
0.4
15.0
|
| Citius Pharma Inc |
|
17.6
|
0.6
|
L
 12.3%
H
0.6
0.7
|
L
 -11.1%
H
0.6
0.8
|
L
 28%
H
0.5
0.8
|
L
 20.8%
H
0.5
0.8
|
L
 -53.6%
H
0.5
2.2
|
L
 -97.2%
H
0.1
26.8
|
L
 -98.5%
H
0.1
58.8
|
L
 -99.7%
H
0.1
371.3
|
| CVRx Inc |
|
75.1
|
2.8
|
L
 2.6%
H
2.7
2.9
|
L
 8.5%
H
2.5
3.2
|
L
 -42.6%
H
2.2
6
|
L
 -52.5%
H
2.2
6.4
|
L
 -59.0%
H
2.2
11.3
|
L
 -83.8%
H
2.2
33.1
|
L
 -85.2%
H
2.2
33.1
|
L
H
2.2
33.1
|
| Delcath Systems Inc |
|
595.1
|
17.2
|
L
 1.7%
H
16.9
17.3
|
L
 -0.4%
H
16.5
17.4
|
L
 33.9%
H
11.5
17.4
|
L
 54.6%
H
10.2
17.4
|
L
 61.0%
H
8.1
17.4
|
L
 242.3%
H
2.3
18.2
|
L
 95.6%
H
2.3
18.2
|
L
 -100.0%
H
2.3
527975000
|
| DarioHealth Corp |
|
70.2
|
7.2
|
L
 -0.3%
H
7.2
7.9
|
L
 -6.7%
H
7.0
7.9
|
L
 5.1%
H
6.1
8.2
|
L
 -14.3%
H
5.8
8.3
|
L
 -20.4%
H
5.8
17.7
|
L
 -87.2%
H
5.8
69.8
|
L
 -96.7%
H
5.8
387.8
|
L
 -99.5%
H
5.8
1880
|
| Alpha Tau Medical Ltd |
|
1,338.2
|
14.5
|
L
 1.5%
H
14.2
14.7
|
L
 1.4%
H
13.4
14.8
|
L
 6.8%
H
11.0
14.8
|
L
 44.3%
H
8.8
14.8
|
L
 343.9%
H
3
14.8
|
L
 291.1%
H
1.8
14.8
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
33,917.2
|
89.9
|
L
 0.3%
H
89.2
91.9
|
L
 0.4%
H
88.1
92.0
|
L
 17.3%
H
69.8
92.0
|
L
 38.1%
H
64.5
92.0
|
L
 11.2%
H
54.1
92.0
|
L
 -15.2%
H
54.1
142
|
L
 -29.4%
H
54.1
164.9
|
L
 295.6%
H
10.7
164.9
|
| ElectroCore Inc |
|
97.5
|
10.8
|
L
 5.3%
H
9.9
10.9
|
L
 18.5%
H
8.7
10.9
|
L
 83.8%
H
5.7
10.9
|
L
 84.5%
H
5.6
10.9
|
L
 101.7%
H
4.4
10.9
|
L
 134.5%
H
4.2
19.5
|
L
 -23.4%
H
2.9
19.5
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
3,441.6
|
23.7
|
L
 0.7%
H
21.7
25.0
|
L
 23.0%
H
19.8
25.0
|
L
 -10.3%
H
17.1
29.5
|
L
 49.7%
H
13.5
30
|
L
 631.5%
H
3.1
30
|
L
 -88.7%
H
2.7
704.0
|
L
 -97.5%
H
2.7
1164.2
|
L
 -99.8%
H
2.7
21532.5
|
| Embecta Corp |
|
307.1
|
5.4
|
L
 6.3%
H
5.1
5.4
|
L
 11.1%
H
4.6
5.4
|
L
 66.8%
H
3.2
5.4
|
L
 78.9%
H
2.8
5.4
|
L
 -59.8%
H
2.8
15.6
|
L
 -70.2%
H
2.8
21.5
|
L
H
2.8
63
|
L
H
2.8
63
|
| Establishment Labs Holdings Inc |
|
2,245.9
|
75.4
|
L
 0.2%
H
74.8
77.6
|
L
 1.5%
H
74.7
81.3
|
L
 -18.6%
H
73.8
97.6
|
L
 14.8%
H
64.5
97.6
|
L
 97.0%
H
36.5
97.6
|
L
 42.9%
H
17
97.6
|
L
 9.8%
H
17
97.6
|
L
H
7.6
97.6
|
| EDAP TMS S.A. (ADR) |
|
163.4
|
4.4
|
L
 2.4%
H
4.2
4.5
|
L
 -27.5%
H
4.1
5.0
|
L
 -19.9%
H
4.1
6.4
|
L
 -1.4%
H
4.0
6.4
|
L
 194.6%
H
1.3
6.4
|
L
 -43.4%
H
1.2
8.5
|
L
 -25.9%
H
1.2
12.7
|
L
 43.9%
H
1.2
12.7
|
| GlucoTrack Inc |
|
3.7
|
0.4
|
L
 2.9%
H
0.3
0.4
|
L
 -5.4%
H
0.3
0.4
|
L
 -28.6%
H
0.3
0.9
|
L
 -27.1%
H
0.3
0.9
|
L
 -93.9%
H
0.3
14.1
|
L
 -100.0%
H
0.3
5940
|
L
 -100.0%
H
0.3
39000
|
L
 -100.0%
H
0.3
468000
|
| GE HealthCare Tech |
|
33,704.8
|
74.6
|
L
 2.7%
H
73.1
75.4
|
L
 2.6%
H
71.0
75.4
|
L
 18.3%
H
60.2
75.4
|
L
 21.3%
H
60.0
75.4
|
L
 2.0%
H
58.8
89.8
|
L
 9.2%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Guardant Health Inc |
|
21,919.6
|
163.3
|
L
 2.0%
H
159.5
168.7
|
L
 -1.1%
H
155
168.7
|
L
 4.8%
H
140.9
176.6
|
L
 70.8%
H
93.4
176.6
|
L
 174.7%
H
53.4
176.6
|
L
 341.3%
H
15.8
176.6
|
L
 65.1%
H
15.8
176.6
|
L
H
15.8
181.1
|
| Harvard Bioscience Inc |
|
32.2
|
7.1
|
L
 1.6%
H
7.0
7.1
|
L
 15.5%
H
6.1
7.2
|
L
 13.6%
H
5.9
7.2
|
L
 41.6%
H
4.9
7.2
|
L
 40.2%
H
3.8
9.4
|
L
 -83.3%
H
2.8
55.6
|
L
 -91.3%
H
2.8
84.8
|
L
 -72.3%
H
2.8
87.5
|
| Cue Health Inc |
|
4,653.4
|
29.3
|
L
 5.2%
H
28.6
29.3
|
L
 5.0%
H
27.3
29.3
|
L
H
24.9
29.3
|
L
H
24.9
29.3
|
L
H
24.9
29.3
|
L
 8257.1%
H
0
29.3
|
L
H
0
29.3
|
L
H
0
29.3
|
| Heart Test Laboratories Inc |
|
9.9
|
2.5
|
L
 19.3%
H
2.1
2.6
|
L
 23.9%
H
2.0
2.6
|
L
 -5.6%
H
1.9
2.6
|
L
 36.6%
H
1.6
3.8
|
L
 -32.3%
H
1.6
3.9
|
L
 -96.5%
H
1.6
85.2
|
L
H
1.6
600
|
L
H
1.6
600
|
| Helius Medical Tech Inc (Class A) |
|
112.5
|
1.9
|
L
 4.5%
H
1.8
1.9
|
L
 6.9%
H
1.6
1.9
|
L
 10.7%
H
1.6
1.9
|
L
 -14.7%
H
1.2
2.4
|
L
 -71.1%
H
1.2
25.5
|
L
 -100.0%
H
1.2
10072.5
|
L
 -100.0%
H
1.2
579375
|
L
 -100.0%
H
1.2
27168750
|
| Henry Schein |
|
9,951.1
|
89.3
|
L
 0.1%
H
89.2
91.3
|
L
 0.1%
H
88.5
91.5
|
L
 1.7%
H
83.2
92.2
|
L
 22.8%
H
71.7
92.2
|
L
 32.8%
H
61.9
92.2
|
L
 16.7%
H
60.0
92.2
|
L
 17.8%
H
60.0
92.7
|
L
 41.1%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
95.4
|
0.9
|
L
H
0.9
0.9
|
L
 -7.2%
H
0.9
1.0
|
L
 -3.2%
H
0.9
1.1
|
L
 -37.9%
H
0.9
1.7
|
L
 -30.2%
H
0.9
2.2
|
L
 -61.2%
H
0.5
2.6
|
L
 -90.9%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,340.8
|
17.2
|
L
 -1.8%
H
17.2
18.4
|
L
 -0.8%
H
17
18.6
|
L
 -10.4%
H
16.0
20.5
|
L
 22.2%
H
13.8
20.5
|
L
 22.7%
H
8.7
20.5
|
L
 -59.3%
H
8.7
45.4
|
L
 -75.9%
H
8.7
76.7
|
L
 -59.6%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
8.6
|
2.5
|
L
 -3.1%
H
2.5
2.8
|
L
 -28.2%
H
2.5
3.4
|
L
 -31.0%
H
2.5
3.6
|
L
 -61.8%
H
2.1
9.5
|
L
 -90.6%
H
2.1
42
|
L
 -91.7%
H
2.1
49.8
|
L
 -99.1%
H
2.1
372
|
L
 -92.7%
H
2.1
480
|
| SeaStar Medical Holding Corp |
|
14.4
|
3.3
|
L
 -2.1%
H
3.3
3.4
|
L
 -11.4%
H
3.0
3.7
|
L
 -18.3%
H
3.0
4.1
|
L
 -18.3%
H
2.6
5.4
|
L
 -96.1%
H
2.1
125
|
L
 -99.5%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
4,682.8
|
187.3
|
L
 1.9%
H
185.3
189.3
|
L
 2.8%
H
177.0
189.3
|
L
 18.9%
H
152.7
192.9
|
L
 52.1%
H
119.7
192.9
|
L
 52.3%
H
112.5
192.9
|
L
 42.1%
H
78.4
196.3
|
L
 -3.3%
H
78.4
282
|
L
 50.8%
H
78.4
321.7
|
| Idexx Laboratories |
|
44,290.7
|
562.2
|
L
 1.6%
H
555
575.6
|
L
 -4.2%
H
538.2
584.2
|
L
 -0.9%
H
534.4
624.2
|
L
 3.0%
H
518.6
624.2
|
L
 -11.9%
H
518.6
770.0
|
L
 16.2%
H
356.3
770.0
|
L
 -16.9%
H
317.1
770.0
|
L
 407.2%
H
102.5
770.0
|
| QTREX Quantum |
|
62.4
|
1.1
|
L
 24.4%
H
0.9
1.4
|
L
 12%
H
0.9
1.4
|
L
 -11.8%
H
0.8
1.4
|
L
 202.7%
H
0.3
3.9
|
L
 -9.7%
H
0.3
3.9
|
L
 -14.5%
H
0.3
3.9
|
L
 -66.6%
H
0.3
9.6
|
L
H
0.3
9.6
|
| Illumina Inc |
|
30,955
|
205
|
L
 8.9%
H
192.7
205.2
|
L
 6.3%
H
187.4
205.2
|
L
 9.8%
H
178.9
207
|
L
 44.9%
H
138.6
207
|
L
 103.9%
H
88
207
|
L
 22.6%
H
68.7
207
|
L
 -59.9%
H
68.7
492.3
|
L
 18.9%
H
68.7
555.8
|
| Intercure Ltd |
|
55.1
|
0.9
|
L
 -2.1%
H
0.9
1.0
|
L
 -3.1%
H
0.9
1
|
L
 1.1%
H
0.9
1
|
L
 13.4%
H
0.8
1.2
|
L
 -42.2%
H
0.7
1.7
|
L
 -34.5%
H
0.7
3.7
|
L
 -84.2%
H
0.7
8.8
|
L
H
0.7
19.4
|
| Inogen Inc |
|
150.7
|
5.7
|
L
 1.4%
H
5.6
5.8
|
L
 -3.7%
H
5.6
5.9
|
L
 -13.6%
H
5.6
6.9
|
L
 -9.8%
H
5.6
7.1
|
L
 -24.8%
H
5.3
9.1
|
L
 -9.7%
H
4.1
13.3
|
L
 -90.8%
H
4.1
61.8
|
L
 -90.0%
H
4.1
287.8
|
| Inmode Ltd |
|
865.5
|
15.0
|
L
 0.3%
H
14.9
15.1
|
L
 -0.7%
H
14.9
15.4
|
L
 -2.8%
H
14.9
15.6
|
L
 6.7%
H
13.2
15.7
|
L
 5.2%
H
12.7
16.7
|
L
 -59.9%
H
12.7
40.4
|
L
 -72.8%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
2.0
|
1.1
|
L
 -21.0%
H
1.1
1.3
|
L
 9.7%
H
1.0
2.8
|
L
 8.7%
H
0.9
2.8
|
L
 -24.7%
H
0.9
3.1
|
L
 -98%
H
0.9
84.4
|
L
 -99.9%
H
0.9
5040
|
L
 -100.0%
H
0.9
123264
|
L
 -100.0%
H
0.9
709632
|
| IRIDEX Corp |
|
13.6
|
0.8
|
L
 -16.1%
H
0.7
0.8
|
L
 -12.4%
H
0.7
1.0
|
L
 -16.1%
H
0.7
1.0
|
L
 -23.5%
H
0.7
1.2
|
L
 -33.3%
H
0.7
1.7
|
L
 -41.4%
H
0.7
3.7
|
L
 -89.5%
H
0.7
9.5
|
L
 -94.2%
H
0.7
16.4
|
| Iradimed Corp |
|
1,117.6
|
87.4
|
L
 -0.2%
H
87.1
89.0
|
L
 -1.7%
H
85
91.2
|
L
 -9.9%
H
85
98.5
|
L
 -1.2%
H
85
103.0
|
L
 24.7%
H
67.8
107.9
|
L
 84.2%
H
36.1
107.9
|
L
 163.3%
H
26
107.9
|
L
 401.7%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
4,112.1
|
124.8
|
L
 8.3%
H
116.0
124.9
|
L
 2.4%
H
114.9
128
|
L
 12.5%
H
105.3
136.7
|
L
 12.5%
H
100.9
136.7
|
L
 -21.0%
H
100.9
212
|
L
 13.4%
H
55.9
212
|
L
 179.0%
H
41.7
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
142,494.3
|
397.7
|
L
 1.7%
H
394
405.3
|
L
 -0.9%
H
389.7
405.3
|
L
 15.1%
H
328.6
405.3
|
L
 -9.6%
H
328.6
449.8
|
L
 -17.4%
H
328.6
603.9
|
L
 39.1%
H
254.9
616
|
L
 14.8%
H
180.1
616
|
L
 422.1%
H
67.9
616
|
| Jowell Global Ltd |
|
5.8
|
2.4
|
L
 -11.6%
H
2.4
2.7
|
L
 -37.6%
H
2.4
3.5
|
L
 19.6%
H
1.5
5.2
|
L
 7.0%
H
1.5
5.2
|
L
 22%
H
1.5
5.2
|
L
 -24.0%
H
1
5.6
|
L
 -96.9%
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
103.3
|
36.0
|
L
H
36.0
36.7
|
L
 -0.5%
H
36
36.9
|
L
 -5.5%
H
35.0
38.7
|
L
 -6.1%
H
33.3
41.2
|
L
 -36.7%
H
33.3
60.9
|
L
 138.2%
H
15.3
71.3
|
L
 170.8%
H
12.1
71.3
|
L
 67.8%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
691.9
|
26.5
|
L
 3.9%
H
25.6
26.7
|
L
 9.3%
H
24
26.7
|
L
 37.9%
H
18.1
26.7
|
L
 46.1%
H
16.4
26.7
|
L
 38.0%
H
14.4
26.7
|
L
 -31.0%
H
14.4
39.0
|
L
 -58.5%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
153.3
|
3.3
|
L
 -0.3%
H
3.3
3.4
|
L
 -3.8%
H
3.3
3.5
|
L
 -19.2%
H
3.2
4.4
|
L
 -13.3%
H
3.2
4.7
|
L
 -21.1%
H
3.2
6.6
|
L
 29.7%
H
1.9
6.6
|
L
 -3.8%
H
1.8
6.6
|
L
 654.5%
H
0.3
12.8
|
| Standard BioTools Inc |
|
263.0
|
0.7
|
L
 1.5%
H
0.7
0.7
|
L
 -15.2%
H
0.7
0.8
|
L
 -25.6%
H
0.7
0.9
|
L
 -32.3%
H
0.7
1.3
|
L
 -47.2%
H
0.7
1.7
|
L
 -75.1%
H
0.7
3.2
|
L
 -89.7%
H
0.7
7.3
|
L
 -92.8%
H
0.7
14.9
|
| LivaNova PLC |
|
4,453.8
|
80.8
|
L
 1.2%
H
80.4
81.7
|
L
 2.9%
H
76.7
82.7
|
L
 0.2%
H
74.7
85.8
|
L
 11.9%
H
70.7
85.8
|
L
 51.8%
H
48.8
85.8
|
L
 49.2%
H
32.5
85.8
|
L
 1.9%
H
32.5
93.9
|
L
 29.0%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,918.0
|
83.9
|
L
 2.9%
H
81.6
84.1
|
L
 1.2%
H
79.9
84.4
|
L
 -17.5%
H
78.7
106.3
|
L
 -16.8%
H
78.7
106.3
|
L
 -11.8%
H
78.7
118.0
|
L
 52.1%
H
44.3
118.0
|
L
 52.8%
H
38.3
118.0
|
L
 383.7%
H
16.8
118.0
|
| LENSAR Inc |
|
107.1
|
8.7
|
L
 6.5%
H
8.0
8.7
|
L
 44.6%
H
6.1
8.7
|
L
 50.3%
H
5.0
8.7
|
L
 54.9%
H
5.0
8.7
|
L
 -31.6%
H
5.0
13.0
|
L
 155.7%
H
1.8
17.3
|
L
 9.5%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,558.6
|
100.5
|
L
 0.2%
H
100.2
100.7
|
L
 -0.2%
H
100.2
101.1
|
L
 -6.6%
H
98.8
109.5
|
L
 7.9%
H
91.7
111.9
|
L
 79.5%
H
49.7
111.9
|
L
 51.6%
H
47.3
126.9
|
L
 310.8%
H
22.2
126.9
|
L
 1239.7%
H
6.6
126.9
|
| Lucid Diagnostics Inc |
|
192.9
|
1.0
|
L
 2.0%
H
1.0
1.0
|
L
 5.2%
H
1.0
1.0
|
L
 6.3%
H
0.9
1.0
|
L
 5.2%
H
0.9
1.2
|
L
 -1.0%
H
0.9
1.6
|
L
 -31.3%
H
0.6
1.8
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
99.2
|
2.3
|
L
 2.2%
H
2.2
2.4
|
L
 2.2%
H
2.1
2.5
|
L
 65%
H
1.2
2.5
|
L
 76.3%
H
1.2
2.5
|
L
 44.4%
H
1.1
2.9
|
L
 -77.7%
H
1.1
14.8
|
L
 -93.7%
H
1.1
45.5
|
L
H
1.1
69.5
|
| 908 Devices Inc |
|
423.3
|
10.2
|
L
 1.6%
H
10.0
10.5
|
L
 2.3%
H
9.3
10.5
|
L
 39.3%
H
6.9
10.5
|
L
 54.2%
H
6.5
10.5
|
L
 63.3%
H
5.0
10.5
|
L
 46.1%
H
1.8
12.5
|
L
 -66.7%
H
1.8
39.8
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
648.6
|
4.5
|
L
 2.5%
H
4.4
4.5
|
L
 3.0%
H
4.1
4.5
|
L
 3.5%
H
3.8
4.5
|
L
 24.0%
H
3.5
4.5
|
L
 -38.1%
H
3.0
8.0
|
L
 -40.2%
H
3.0
10.1
|
L
 -63.8%
H
2.4
16.0
|
L
 -39.4%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
669.9
|
119.7
|
L
 10.9%
H
108.9
120.5
|
L
 7.6%
H
103.9
120.5
|
L
 22.2%
H
93.0
120.5
|
L
 18.2%
H
81.3
120.5
|
L
 75.0%
H
58.8
120.5
|
L
 -13.3%
H
55.5
155.1
|
L
 -56.2%
H
55.5
333.4
|
L
 16.1%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
5,492.2
|
92.0
|
L
 3.1%
H
90.0
92.0
|
L
 1.0%
H
89.1
92.3
|
L
 24.3%
H
71.6
92.3
|
L
 44.5%
H
60.0
92.3
|
L
 6.8%
H
59.7
94.8
|
L
 35.3%
H
59.7
111.5
|
L
 37.2%
H
50.5
111.5
|
L
 285.7%
H
19.5
111.5
|
| Modular Medical Inc |
|
18.0
|
3.3
|
L
 9.6%
H
3.0
3.6
|
L
 64.4%
H
1.7
3.6
|
L
 11.4%
H
1.7
3.6
|
L
 -1.2%
H
1.7
6
|
L
 -84.2%
H
1.7
30
|
L
 -90.9%
H
1.7
79.5
|
L
 -99.1%
H
1.7
450
|
L
 -86.3%
H
1.7
585.0
|
| MedTech Acq Corp (Class A) |
|
-
|
5.5
|
L
 1.7%
H
5.4
5.6
|
L
 -4.4%
H
5.2
5.9
|
L
 28.0%
H
4
5.9
|
L
 81.2%
H
3.0
5.9
|
L
 13.0%
H
2.2
8.0
|
L
 6.8%
H
2.2
8.0
|
L
 -44.0%
H
2.2
12.8
|
L
H
2.2
12.8
|
| Myriad Genetics Inc |
|
305.1
|
3.2
|
L
 11.2%
H
2.9
3.2
|
L
 -0.9%
H
2.8
3.3
|
L
 -48.4%
H
2.7
6.2
|
L
 -12.6%
H
2.7
6.4
|
L
 -44.1%
H
2.7
8.6
|
L
 -81.3%
H
2.7
29.3
|
L
 -90.3%
H
2.7
37.0
|
L
 -85.0%
H
2.7
50.4
|
| MDxHealth SA (ADR) |
|
-
|
0.8
|
L
 1.3%
H
0.8
0.8
|
L
 72.7%
H
0.4
1.1
|
L
 81.0%
H
0.4
1.1
|
L
 -10.6%
H
0.4
1.1
|
L
 -74.5%
H
0.4
5.3
|
L
 -78.3%
H
0.4
5.3
|
L
H
0.4
13.2
|
L
H
0.4
13.2
|
| ENvue Medical Inc |
|
3.9
|
0.4
|
L
 -2.3%
H
0.4
0.4
|
L
 5%
H
0.3
0.5
|
L
H
0.3
0.5
|
L
 -58.4%
H
0.3
1.1
|
L
 -93.4%
H
0.3
17.4
|
L
 -99.8%
H
0.3
465.3
|
L
 -100.0%
H
0.3
7194
|
L
 -100.0%
H
0.3
18700
|
| ENDRA Life Sciences Inc |
|
5.7
|
4.5
|
L
 0.2%
H
4.5
4.6
|
L
 2.5%
H
4.3
4.6
|
L
 -9.4%
H
4.1
5.9
|
L
 -16.5%
H
3.6
6.7
|
L
 -6.2%
H
3.0
9.9
|
L
 -91.8%
H
0.0
139.5
|
L
 -99.7%
H
0.0
2090
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,649.4
|
12.2
|
L
 5.0%
H
11.6
12.3
|
L
 5.7%
H
11.3
12.3
|
L
 18.3%
H
9.1
12.9
|
L
 41.9%
H
8.2
12.9
|
L
 119.3%
H
4.9
12.9
|
L
 -46%
H
3.9
23.6
|
L
 -71.4%
H
3.9
47.8
|
L
 -42.7%
H
3.9
48.9
|
| Nephros Inc |
|
51.7
|
4.8
|
L
 3.7%
H
4.6
4.9
|
L
 11.5%
H
4.0
4.9
|
L
 25.9%
H
3.2
4.9
|
L
 29.4%
H
3.1
4.9
|
L
 10.7%
H
2.7
6.4
|
L
 209.1%
H
1.4
6.4
|
L
 -37.4%
H
0.9
9.1
|
L
 23.3%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
19.9
|
2.2
|
L
 16.0%
H
1.9
2.4
|
L
 36.3%
H
1.5
2.4
|
L
 -6.8%
H
1.4
2.4
|
L
 -51.9%
H
1.4
4.5
|
L
 -56.2%
H
1.4
7.0
|
L
 -64.0%
H
1.4
12
|
L
 -92.1%
H
1.4
40.8
|
L
H
1.4
180
|
| Nano X Imaging Ltd |
|
69.1
|
0.9
|
L
 4.5%
H
0.9
0.9
|
L
 -16.2%
H
0.9
1.1
|
L
 -17.0%
H
0.9
1.2
|
L
 -45.3%
H
0.7
2.1
|
L
 -78.2%
H
0.7
4.7
|
L
 -89.3%
H
0.7
14.3
|
L
 -96.1%
H
0.7
28.6
|
L
H
0.7
94.8
|
| NeuroPace Inc |
|
502.5
|
14.6
|
L
 1.2%
H
14.5
15.3
|
L
 -2.7%
H
14.0
15.3
|
L
 -9.0%
H
12.7
16.4
|
L
 -8.4%
H
12.7
18.2
|
L
 73.9%
H
8.2
19.6
|
L
 226.1%
H
4.4
19.6
|
L
 -23.9%
H
1.2
24.7
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
42.6
|
0.9
|
L
 3.4%
H
0.9
1.0
|
L
 7.1%
H
0.8
1.0
|
L
 30%
H
0.7
1.0
|
L
 -13.3%
H
0.6
1.1
|
L
 -63.5%
H
0.6
2.6
|
L
 -72.3%
H
0.6
3.9
|
L
 -75.9%
H
0.6
5.1
|
L
 -100.0%
H
0.6
115237.5
|
| Nortech Systems Inc |
|
34.4
|
12.1
|
L
 -1.2%
H
12.0
12.3
|
L
 -19.0%
H
11.8
15.6
|
L
 -13.1%
H
11.8
15.7
|
L
 -2.7%
H
11.8
18.0
|
L
 37.9%
H
6.5
18.0
|
L
 23.5%
H
6.5
19.2
|
L
 10.0%
H
6.5
19.6
|
L
 211.4%
H
2.5
19.6
|
| Nutriband Inc |
|
43.2
|
3.6
|
L
 2.9%
H
3.4
3.6
|
L
 11.6%
H
3.1
3.6
|
L
 14.2%
H
2.8
3.6
|
L
 3.8%
H
2.8
3.7
|
L
 -44.2%
H
2.8
8.6
|
L
 4.4%
H
1.5
11.8
|
L
 -48.3%
H
1.5
12.9
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
0.2
|
1.2
|
L
 -1.7%
H
1.1
1.3
|
L
 -21.0%
H
1.1
1.5
|
L
 -59.0%
H
1.1
6.4
|
L
 19.4%
H
0.1
6.4
|
L
 -81.4%
H
0.1
6.4
|
L
 -100.0%
H
0.1
3895.5
|
L
 -100.0%
H
0.1
698250
|
L
 -100.0%
H
0.1
10000000000
|
| NovoCure Ltd |
|
2,119.3
|
18.2
|
L
 5.6%
H
17.4
18.3
|
L
 3.1%
H
16.8
18.3
|
L
 14.3%
H
14.8
21.5
|
L
 4.2%
H
13.4
21.5
|
L
 50.5%
H
9.8
21.5
|
L
 -41.4%
H
9.8
34.1
|
L
 -86.2%
H
9.8
143.7
|
L
 126.9%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.2
|
10.5
|
L
 -5.1%
H
10.5
11.3
|
L
 -5.8%
H
10.2
12.5
|
L
 -3.0%
H
9.8
12.5
|
L
 6.6%
H
9.7
12.5
|
L
 -94.0%
H
8.7
177.4
|
L
 -93.8%
H
8.7
244.0
|
L
 -96.0%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
7.3
|
0.3
|
L
H
0.3
0.3
|
L
 -8.3%
H
0.3
0.4
|
L
 -31.3%
H
0.3
0.5
|
L
 3.1%
H
0.3
0.6
|
L
 -58.8%
H
0.3
2
|
L
 -44.1%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
165.1
|
1.7
|
L
 3.1%
H
1.6
1.7
|
L
 3.8%
H
1.5
1.7
|
L
 5.1%
H
1.3
1.7
|
L
 -43.5%
H
1.3
3.1
|
L
 -74.9%
H
1.3
6.9
|
L
 -79.6%
H
1.3
20
|
L
 -94.7%
H
1.3
34.2
|
L
H
1.3
37
|
| Orchestra BioMed Holdings Inc |
|
333.6
|
5.6
|
L
 -1.9%
H
5.5
5.8
|
L
 26.1%
H
4.2
5.8
|
L
 50.8%
H
3.6
5.8
|
L
 39.5%
H
3.6
5.8
|
L
 111.0%
H
2.2
5.8
|
L
 4.1%
H
2.2
11.7
|
L
 -43.7%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
426.9
|
10.5
|
L
 2.5%
H
10.2
10.7
|
L
 1.6%
H
10.0
10.7
|
L
 -9.5%
H
10.0
12.6
|
L
 -13.7%
H
8.9
12.6
|
L
 -27.8%
H
8.9
17.0
|
L
 -42.5%
H
8.9
21.6
|
L
 -73.7%
H
8.9
43.3
|
L
 -76.3%
H
8.9
74.4
|
| Outset Medical Inc |
|
80.8
|
4.3
|
L
 2.9%
H
4.2
4.4
|
L
 -10.8%
H
4.1
5.0
|
L
 2.4%
H
4.0
5.3
|
L
 15.6%
H
3.6
5.5
|
L
 -68.5%
H
3
16.2
|
L
 -98.0%
H
0.5
218.9
|
L
 -99.3%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
245.8
|
1.9
|
L
 6.7%
H
1.8
2.0
|
L
 1.1%
H
1.7
2.0
|
L
 -27.1%
H
1.5
2.7
|
L
 -23.0%
H
1.5
2.7
|
L
 -58.3%
H
1.5
7.1
|
L
 -27.9%
H
1.5
7.1
|
L
 -86.4%
H
1.5
17.5
|
L
H
1.5
310.9
|
| Orasure Tech Inc |
|
255.2
|
3.7
|
L
 -1.3%
H
3.7
3.9
|
L
 -4.6%
H
3.7
4.1
|
L
 -4.4%
H
3.7
4.2
|
L
 22.9%
H
3.0
4.6
|
L
 32.1%
H
2.1
4.6
|
L
 -44.4%
H
2.1
8.5
|
L
 -63.8%
H
2.1
13.6
|
L
 -46.6%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
394.8
|
1.3
|
L
 11.4%
H
1.2
1.3
|
L
 11.4%
H
1.1
1.3
|
L
 -11.8%
H
1.1
1.5
|
L
 10.4%
H
1.1
1.8
|
L
 -4.5%
H
1.1
2.7
|
L
 -87.7%
H
0.9
12.0
|
L
 -95.3%
H
0.9
32.6
|
L
 -86.1%
H
0.9
53.7
|
| PAVmed Inc |
|
40.8
|
5.1
|
L
 0.8%
H
4.9
5.3
|
L
 8.3%
H
4.2
5.4
|
L
 -13.9%
H
4.2
5.9
|
L
 -17.9%
H
3.9
6.7
|
L
 -60.6%
H
3.9
28.4
|
L
 -95.3%
H
3.9
270
|
L
 -99.8%
H
3.9
4365
|
L
 -99.9%
H
3.9
6520.5
|
| Pro-Dex Inc (co) |
|
213.7
|
66.9
|
L
 0.1%
H
65.5
68.3
|
L
 0.3%
H
61.7
69.9
|
L
 16.7%
H
53
69.9
|
L
 13.2%
H
53
69.9
|
L
 51.8%
H
23.5
69.9
|
L
 314.7%
H
14.5
70.3
|
L
 117.3%
H
12.4
70.3
|
L
 1355.2%
H
3.8
70.3
|
| Pulse Biosciences Inc |
|
3,353.6
|
47.0
|
L
 2.2%
H
46.1
48.8
|
L
 5.9%
H
42.3
48.8
|
L
 64.0%
H
27.4
48.8
|
L
 83.6%
H
23.6
48.8
|
L
 199.9%
H
12.6
48.8
|
L
 461.1%
H
3.8
48.8
|
L
 116.6%
H
1.2
48.8
|
L
 917.7%
H
1.2
48.8
|
| Axe Compute Inc |
|
125.3
|
10.9
|
L
 5.5%
H
9.7
10.9
|
L
 36.1%
H
7.4
10.9
|
L
 58.7%
H
6.6
10.9
|
L
 132.9%
H
4.2
10.9
|
L
 -14.8%
H
1.0
32.1
|
L
 -84.6%
H
1.0
73.8
|
L
 -96.6%
H
1.0
439.8
|
L
 -99.8%
H
1.0
20250
|
| Precision Optics Corp Inc |
|
48.6
|
4.4
|
L
 2.3%
H
4.3
4.5
|
L
 4.7%
H
4.1
4.5
|
L
 2.3%
H
4.1
4.6
|
L
 -12.6%
H
4.1
6.2
|
L
 -4.1%
H
3.6
6.2
|
L
 -27.2%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
10,507.9
|
151.5
|
L
 2.4%
H
148.0
155.2
|
L
 4.7%
H
138.3
155.2
|
L
 -7.7%
H
126.4
172.9
|
L
 -0.6%
H
126.4
172.9
|
L
 -53.1%
H
126.4
354.9
|
L
 -26.1%
H
125.8
354.9
|
L
 -49.0%
H
125.8
354.9
|
L
 246.4%
H
30.7
354.9
|
| Procept BioRobotics Corp |
|
1,254.9
|
21.9
|
L
 2.8%
H
21.6
22.2
|
L
 -4.3%
H
20.8
22.8
|
L
 14%
H
16.7
22.9
|
L
 -15.8%
H
16.7
29.7
|
L
 -46.2%
H
16.7
42.4
|
L
 -27.0%
H
16.7
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Profound Medical Corp |
|
258.7
|
7.1
|
L
 1.1%
H
7
7.3
|
L
 1.4%
H
6.5
7.3
|
L
 3.4%
H
6.5
8.5
|
L
 2.8%
H
6.3
8.5
|
L
 49.1%
H
3.8
9.0
|
L
 -19.4%
H
3.8
11.7
|
L
 -51.4%
H
3.1
16.3
|
L
 -38.2%
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
946.3
|
13.8
|
L
 2.8%
H
13.7
14.3
|
L
 -1.4%
H
13.2
15.5
|
L
 -20.6%
H
11.4
18.0
|
L
 27.3%
H
10.6
19.8
|
L
 -46.6%
H
9.9
35.6
|
L
 -81.4%
H
9.9
84.6
|
L
 -88.3%
H
9.9
180.1
|
L
 -36.0%
H
9.9
306.7
|
| Quanterix Corp |
|
140.0
|
3.0
|
L
 10.5%
H
2.7
3.0
|
L
 13.0%
H
2.5
3.1
|
L
 -23.3%
H
2.2
4.1
|
L
 17.5%
H
2.2
4.6
|
L
 -40.2%
H
2.2
8.8
|
L
 -87.9%
H
2.2
29.7
|
L
 -93.6%
H
2.2
60.9
|
L
H
2.2
92.6
|
| AVITA Medical Inc |
|
319.8
|
10.3
|
L
 5.0%
H
9.3
10.4
|
L
 26.1%
H
7.7
10.4
|
L
 102.8%
H
4.2
10.4
|
L
 146.8%
H
3.7
10.4
|
L
 86.3%
H
3.2
10.4
|
L
 -34.7%
H
3.2
18.9
|
L
 -39.6%
H
3.2
21.7
|
L
 49.9%
H
3.2
55.4
|
| Rosecliff Acq Corp I (Class A) |
|
-
|
1.6
|
L
 0.6%
H
1.6
1.6
|
L
 -5.3%
H
1.5
1.8
|
L
 -3.0%
H
1.5
1.8
|
L
 -27.7%
H
1.5
3.0
|
L
 -23.6%
H
1.2
3.0
|
L
 -85.7%
H
1.2
19.5
|
L
 -83.2%
H
1.2
19.5
|
L
H
1.2
19.5
|
| Rockwell Medical Inc |
|
30.2
|
7.5
|
L
 -0.3%
H
7.4
7.7
|
L
 5.9%
H
6.9
8.0
|
L
 22.6%
H
6.1
8.0
|
L
 -4.0%
H
4.9
8.4
|
L
 -28.6%
H
4.9
21
|
L
 -66.1%
H
4.9
51.5
|
L
 -88.6%
H
4.9
77
|
L
 -99.1%
H
4.9
987.8
|
| Vyome Holdings Inc |
|
16.3
|
2.3
|
L
 2.2%
H
2.2
2.4
|
L
 3.1%
H
2.1
2.4
|
L
 7.9%
H
2.0
2.4
|
L
 22.8%
H
1.8
2.5
|
L
 -73.4%
H
1.8
12
|
L
 -96.7%
H
0.3
74.8
|
L
 -100.0%
H
0.3
11716
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
437.0
|
7.3
|
L
 -1.9%
H
7.2
7.6
|
L
 -3.8%
H
7.2
8
|
L
 -8.1%
H
6.8
8
|
L
 10.5%
H
6
9.6
|
L
 1035.9%
H
0.4
9.6
|
L
 69.5%
H
0.4
9.6
|
L
 -20.1%
H
0.4
19.5
|
L
 -99.3%
H
0.4
1137.5
|
| Sight Sciences Inc |
|
466.6
|
8.5
|
L
 3.0%
H
8.3
8.9
|
L
 9.3%
H
7.6
8.9
|
L
 68.4%
H
4.4
8.9
|
L
 74.3%
H
4.2
8.9
|
L
 102.2%
H
3.2
9.2
|
L
 16.0%
H
1.0
9.2
|
L
 -77.9%
H
1.0
38.8
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,422.1
|
19
|
L
 2.7%
H
18.6
19.2
|
L
 -0.6%
H
18.4
19.2
|
L
 7.0%
H
16.8
19.8
|
L
 23.8%
H
14.8
19.8
|
L
 20.3%
H
13.1
19.9
|
L
 17.1%
H
9.5
19.9
|
L
 -16.0%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
892.3
|
19.9
|
L
 4.0%
H
19.1
19.9
|
L
 5.9%
H
18.4
19.9
|
L
 14.6%
H
16.3
19.9
|
L
 34.9%
H
13.4
19.9
|
L
 28.1%
H
11.5
21.9
|
L
 -7.0%
H
11.5
23.3
|
L
 0.2%
H
11.1
29.5
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
10.6
|
1.6
|
L
 -1.9%
H
1.6
1.7
|
L
 -10.2%
H
1.5
1.8
|
L
H
1.4
1.9
|
L
 -28.7%
H
1.4
2.5
|
L
 -50%
H
1.4
6.8
|
L
 -99.2%
H
0.1
222
|
L
 -100.0%
H
0.1
30200
|
L
 -100.0%
H
0.1
10080000
|
| Beauty Health Co (Class A) |
|
78.1
|
0.6
|
L
H
0.6
0.6
|
L
 -14.3%
H
0.6
0.7
|
L
 -28.6%
H
0.6
0.9
|
L
 -1.6%
H
0.6
1.2
|
L
 -72.6%
H
0.6
2.7
|
L
 -90.7%
H
0.6
7.2
|
L
 -97.3%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
315.0
|
34.3
|
L
 0.3%
H
34.2
34.3
|
L
 -0.3%
H
34.0
34.4
|
L
 37.1%
H
24.8
34.4
|
L
 56.6%
H
20.4
34.4
|
L
 8.6%
H
16.1
36.0
|
L
 -13.8%
H
16.1
43.3
|
L
 2.7%
H
16.1
50.2
|
L
 572.2%
H
2
75
|
| Sensus Healthcare Inc |
|
49.6
|
3.0
|
L
 0.3%
H
3.0
3.1
|
L
 -2.9%
H
2.8
3.3
|
L
 -0.3%
H
2.8
3.3
|
L
 -13.3%
H
2.7
3.6
|
L
 -9.1%
H
2.7
5.5
|
L
 -3.2%
H
1.8
9.3
|
L
 -9.9%
H
1.8
15.3
|
L
 -53.6%
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,236.6
|
24.7
|
L
 0.1%
H
24.4
25.6
|
L
 -1.1%
H
23.3
26.2
|
L
 -6.7%
H
21.2
26.4
|
L
 -23.7%
H
21.2
33.9
|
L
 -11.9%
H
15.6
35.9
|
L
 -42.7%
H
13.5
52.7
|
L
 -82.8%
H
13.5
163.1
|
L
 173.7%
H
7.5
163.1
|
| Neuronetics Inc |
|
239.3
|
3.1
|
L
 -0.3%
H
3.0
3.3
|
L
 -1.6%
H
3.0
3.4
|
L
 93.8%
H
1.7
3.4
|
L
 166.1%
H
1.1
3.4
|
L
 -11.3%
H
0.8
3.8
|
L
 86.9%
H
0.5
5.9
|
L
 -59.8%
H
0.5
8.1
|
L
H
0.5
39.4
|
| SkyAI Inc |
|
54.9
|
1.3
|
L
 28.3%
H
1.0
1.4
|
L
 9.5%
H
1.0
1.4
|
L
 9.5%
H
1.0
1.5
|
L
 -29.4%
H
0.9
2.0
|
L
 -74.9%
H
0.9
18.2
|
L
 -100.0%
H
0.0
5965.7
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
534.6
|
23.6
|
L
 -1.1%
H
23.4
24.7
|
L
 -2.3%
H
23.3
24.9
|
L
 -17.9%
H
23
30.4
|
L
 -0.2%
H
23
32.4
|
L
 87.6%
H
12.5
37.8
|
L
 32.7%
H
8.6
37.8
|
L
 -42.3%
H
6.3
46.4
|
L
 78.1%
H
6.3
76.6
|
| TELA Bio Inc |
|
29.2
|
0.7
|
L
 1.6%
H
0.6
0.7
|
L
 -17.7%
H
0.6
0.9
|
L
 -11.0%
H
0.6
1
|
L
 -21.7%
H
0.6
1.0
|
L
 -61.8%
H
0.5
1.9
|
L
 -92.8%
H
0.5
9.9
|
L
 -95.4%
H
0.5
14.3
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
0.4
|
0.1
|
L
 -18.8%
H
0.1
0.1
|
L
 -58.1%
H
0.1
1.3
|
L
 -74%
H
0.1
1.3
|
L
 -84.9%
H
0.1
1.3
|
L
 -96.1%
H
0.1
3.7
|
L
 -99.9%
H
0.1
114.4
|
L
H
0.1
11050
|
L
H
0.1
11050
|
| Treace Medical Concepts Inc |
|
296.6
|
4.6
|
L
 2.5%
H
4.4
4.6
|
L
 -3.8%
H
4.4
4.9
|
L
 6.1%
H
3.9
5.2
|
L
 65.8%
H
2.5
5.2
|
L
 -35.2%
H
1.2
7.8
|
L
 -72.7%
H
1.2
16.7
|
L
 -81.9%
H
1.2
31.0
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
3,258.4
|
94.0
|
L
 3.6%
H
90.2
95.0
|
L
 5.2%
H
86.1
95.0
|
L
 27.0%
H
68
95.0
|
L
 37.5%
H
64.7
95.0
|
L
 -25.2%
H
60.1
156
|
L
 43.6%
H
36.4
177.4
|
L
 245.5%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,632.3
|
23.5
|
L
 -1.1%
H
23.4
24.8
|
L
 0.1%
H
21.7
24.8
|
L
 37.4%
H
16.1
24.8
|
L
 73.4%
H
13.5
24.8
|
L
 116.4%
H
10.3
29.7
|
L
 -19.6%
H
10.0
53.7
|
L
 -79.0%
H
10.0
155.9
|
L
 -64.0%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
7.4
|
11.0
|
L
 -11.4%
H
10.4
12.3
|
L
 -17.7%
H
10.4
13.2
|
L
 9.2%
H
7.9
14.2
|
L
 -35.6%
H
7.9
22.5
|
L
 -99.1%
H
7.9
1477.5
|
L
 -99.9%
H
7.9
17212.5
|
L
 -100.0%
H
7.9
57187.5
|
L
 -100.0%
H
7.9
256500
|
| Utah Medical Products Inc |
|
229.6
|
72.1
|
L
 0.2%
H
72
73.5
|
L
 0.3%
H
70.0
73.5
|
L
 3.3%
H
63.8
75.0
|
L
 12.7%
H
63.1
75.8
|
L
 26.2%
H
53.7
75.8
|
L
 -21.7%
H
51.3
93.9
|
L
 -17.5%
H
51.3
133.9
|
L
 13.4%
H
51.3
133.9
|
| Vivani Medical Inc |
|
125.4
|
1.4
|
L
 -4.1%
H
1.3
1.5
|
L
H
1.3
1.5
|
L
 5.3%
H
1.2
1.5
|
L
 21.9%
H
1.1
1.7
|
L
 12.1%
H
0.9
1.9
|
L
 36.3%
H
0.8
7.8
|
L
 -86.6%
H
0.8
12.7
|
L
 -98.5%
H
0.8
90.2
|
| Veracyte Inc |
|
3,391.7
|
42.2
|
L
 3.7%
H
40.1
42.5
|
L
 -9.1%
H
40.1
46.8
|
L
 -28.7%
H
40.1
60.0
|
L
 1.7%
H
40.1
60.9
|
L
 40.3%
H
28.3
60.9
|
L
 70.2%
H
18.6
60.9
|
L
 13.9%
H
14.9
60.9
|
L
 717.6%
H
5.1
86.0
|
| Varex Imaging Corp |
|
778.1
|
18.5
|
L
H
18.5
18.5
|
L
 -0.7%
H
18.5
18.6
|
L
 75.0%
H
10.4
18.6
|
L
 90.3%
H
9.3
18.6
|
L
 67.4%
H
9.1
18.6
|
L
 -7.4%
H
6.8
21.5
|
L
 -32.8%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
3.9
|
0.3
|
L
 -3.5%
H
0.3
0.3
|
L
 -12.5%
H
0.3
0.4
|
L
 -33.3%
H
0.3
0.5
|
L
 -53.3%
H
0.3
1.4
|
L
 -93.7%
H
0.3
4.9
|
L
 -96.4%
H
0.3
48.8
|
L
 -99.7%
H
0.3
177.3
|
L
H
0.3
360.3
|
| Wrap Tech Inc |
|
99.5
|
1.6
|
L
 1.9%
H
1.6
1.6
|
L
 -13.9%
H
1.5
2.0
|
L
 -21.5%
H
1.5
2.1
|
L
 8.8%
H
1.0
2.7
|
L
 15%
H
1.0
3.2
|
L
 -7.5%
H
1.0
7.0
|
L
 -78.9%
H
1.0
7.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
0.2
|
5.2
|
L
 -9.1%
H
5.1
6.0
|
L
 -10.8%
H
5.1
7.2
|
L
 -6.6%
H
5.0
7.7
|
L
 -45.8%
H
5.0
10.5
|
L
 -89.2%
H
5.0
95.6
|
L
 -99.5%
H
5.0
1336
|
L
 -99.8%
H
5.0
6564
|
L
H
5.0
18000
|
| DENTSPLY Sirona Inc |
|
2,198.9
|
11.0
|
L
 -0.7%
H
11.0
11.6
|
L
 -5%
H
11.0
11.9
|
L
 -21.5%
H
11.0
14.4
|
L
 12.3%
H
9.4
14.4
|
L
 -20.4%
H
9.4
14.9
|
L
 -70.4%
H
9.4
38.4
|
L
 -81.7%
H
9.4
63.1
|
L
 -81.6%
H
9.4
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
7.3
|
3.0
|
L
 -7.7%
H
2.7
3.0
|
L
 12.5%
H
2.6
3.5
|
L
 4.9%
H
2.5
3.5
|
L
 10.4%
H
2.0
3.5
|
L
 -86.3%
H
2.0
41.1
|
L
 -80.7%
H
2.0
79.8
|
L
 -94.8%
H
2.0
90.4
|
L
 -96.6%
H
2.0
107.0
|
| 111 Inc (ADR) |
|
30.9
|
3.5
|
L
 -1.1%
H
3.5
3.6
|
L
 -6.9%
H
3.5
3.9
|
L
 -3.3%
H
3.5
4.1
|
L
 -40%
H
3.5
6.0
|
L
 -50.9%
H
2.5
11.2
|
L
 19.8%
H
0.4
11.3
|
L
 -35.8%
H
0.4
11.3
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
226.9
|
3.1
|
L
H
3.0
3.3
|
L
 3.4%
H
2.5
3.7
|
L
 62.1%
H
1.5
3.7
|
L
 29.4%
H
1.5
4.5
|
L
 -74.8%
H
1.5
17.2
|
L
 -76.1%
H
1.5
509.9
|
L
H
1.5
509.9
|
L
H
1.5
509.9
|
| HeartBeam Inc |
|
27.0
|
0.5
|
L
H
0.5
0.5
|
L
 -18.6%
H
0.5
0.6
|
L
 -14.3%
H
0.5
0.6
|
L
 -50%
H
0.5
1.0
|
L
 -59.7%
H
0.5
4
|
L
 -69.6%
H
0.5
4
|
L
 -69.6%
H
0.5
4
|
L
 -69.6%
H
0.5
4
|
| TriSalus Life Sciences Inc |
|
338.0
|
5.5
|
L
 1.7%
H
5.4
5.6
|
L
 -4.4%
H
5.2
5.9
|
L
 28.0%
H
4
5.9
|
L
 81.2%
H
3.0
5.9
|
L
 13.0%
H
2.2
8.0
|
L
 -18.9%
H
2.2
10.4
|
L
 -18.9%
H
2.2
10.4
|
L
 -18.9%
H
2.2
10.4
|
| Cencora |
|
60,511.3
|
317.1
|
L
 0.3%
H
312.0
322.5
|
L
 -5.0%
H
302.0
323.6
|
L
 3.0%
H
298.4
334.0
|
L
 21.1%
H
261.3
334.0
|
L
 9.2%
H
244.8
377.5
|
L
 75.8%
H
171.7
377.5
|
L
 167.4%
H
113.7
377.5
|
L
 256.4%
H
68.4
377.5
|
| Spectral AI Inc (Class A) |
|
52.1
|
1.6
|
L
 0.6%
H
1.6
1.6
|
L
 -5.3%
H
1.5
1.8
|
L
 -3.0%
H
1.5
1.8
|
L
 -27.7%
H
1.5
3.0
|
L
 -23.6%
H
1.2
3.0
|
L
H
0.8
13
|
L
H
0.8
13
|
L
H
0.8
13
|
| Envoy Medical Inc (Class A) |
|
57.1
|
0.7
|
L
H
0.7
0.8
|
L
 -3.9%
H
0.7
0.8
|
L
 5.7%
H
0.6
0.8
|
L
 4.2%
H
0.6
0.9
|
L
 -45.2%
H
0.4
1.9
|
L
H
0.4
11.5
|
L
H
0.4
11.5
|
L
H
0.4
11.5
|
| Autonomix Medical Inc |
|
5.7
|
5.9
|
L
 -4.2%
H
5.8
6.2
|
L
 -35.2%
H
5.8
9.3
|
L
 32.8%
H
2.4
24.7
|
L
 -10.7%
H
2.4
24.7
|
L
 -74.9%
H
2.4
32.6
|
L
H
2.4
3192
|
L
H
2.4
3192
|
L
H
2.4
3192
|
| Rewalk Robotics Ltd |
|
-
|
7.3
|
L
 -1.9%
H
7.2
7.6
|
L
 -3.8%
H
7.2
8
|
L
 -8.1%
H
6.8
8
|
L
 10.5%
H
6
9.6
|
L
 -5.2%
H
4.1
10.6
|
L
 -85.9%
H
4.1
109.2
|
L
 -93.3%
H
4.1
233.5
|
L
 -99.9%
H
4.1
13650
|
| GRAIL Inc |
|
3,303.5
|
74.0
|
L
 4.3%
H
72.2
77.1
|
L
 -2.0%
H
66.4
77.1
|
L
 1.9%
H
60.8
77.1
|
L
 21.8%
H
54.5
79.5
|
L
 125.5%
H
30.0
118.8
|
L
H
12.6
118.8
|
L
H
12.6
118.8
|
L
H
12.6
118.8
|
| Work Medical Tech Grp Ltd |
|
5.2
|
2.2
|
L
 -2.3%
H
2.1
2.2
|
L
 -3.6%
H
2.0
3.2
|
L
 8.0%
H
1.8
3.2
|
L
 -94.3%
H
1.8
29.5
|
L
 -100%
H
1.8
930000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
| iTonic Holdings Ordinary |
|
5.3
|
0.3
|
L
 10.7%
H
0.3
0.3
|
L
 6.9%
H
0.2
0.4
|
L
 10.7%
H
0.2
0.4
|
L
 3.3%
H
0.2
1.2
|
L
 -51.6%
H
0.2
1.2
|
L
H
0.2
32
|
L
H
0.2
32
|
L
H
0.2
32
|
| Ceribell Inc |
|
955.2
|
24.9
|
L
 2.8%
H
24.5
25.3
|
L
 16.8%
H
21.1
25.3
|
L
 33.0%
H
16.0
25.3
|
L
 50.1%
H
16.0
25.3
|
L
 104.4%
H
10.9
25.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
958.0
|
9.8
|
L
 2.6%
H
9.4
10.1
|
L
 7.2%
H
8.6
10.1
|
L
 16.3%
H
7.7
10.1
|
L
 29.9%
H
7.4
11.1
|
L
 158.7%
H
3.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
| Beta Bionics Inc |
|
900.2
|
20.0
|
L
 5.2%
H
19.3
20.4
|
L
 13.6%
H
16.8
20.4
|
L
 15.7%
H
12.7
20.4
|
L
 112.9%
H
9.2
20.4
|
L
 15.9%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| DataMEDS AI Inc |
|
4.4
|
1.4
|
L
 3.6%
H
1.3
1.6
|
L
 2.9%
H
1.3
1.7
|
L
 -46.0%
H
1.3
3.9
|
L
 -83.6%
H
1.3
11.6
|
L
 -96.2%
H
1.3
94.5
|
L
H
1.3
352
|
L
H
1.3
352
|
L
H
1.3
352
|
| Anbio biotech (Class A) |
|
340.2
|
7.8
|
L
 -7.2%
H
7.7
8.4
|
L
 -25.1%
H
7.1
13.8
|
L
 -18.3%
H
7.1
13.8
|
L
 -72.5%
H
7.1
36.1
|
L
 -85%
H
7.1
54.5
|
L
H
5.2
55.7
|
L
H
5.2
55.7
|
L
H
5.2
55.7
|
| Kestra Medical Tech Ltd |
|
1,635.6
|
27.9
|
L
 -0.1%
H
27.7
28.9
|
L
 0.0%
H
26.5
28.9
|
L
 14.3%
H
20.4
28.9
|
L
 42.5%
H
17.9
28.9
|
L
 73.5%
H
15.4
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
44.0
|
5.1
|
L
 1.8%
H
4.9
5.2
|
L
 -6.9%
H
4.7
5.6
|
L
 -19.9%
H
4.7
6.7
|
L
 -69.6%
H
4.7
17.5
|
L
 -86.7%
H
4.7
45.3
|
L
 -84.2%
H
4.7
46.6
|
L
 -84.2%
H
4.7
46.6
|
L
 -84.2%
H
4.7
46.6
|
| SS Innovations Intl Inc |
|
721.4
|
3.6
|
L
 -3.0%
H
3.6
3.8
|
L
 -0.3%
H
3.6
4
|
L
 -1.1%
H
3.4
4.2
|
L
 -10%
H
3.2
4.4
|
L
 -45.0%
H
3.1
10
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| CapsoVision Inc |
|
306.3
|
6.1
|
L
 -0.5%
H
6.1
6.3
|
L
 -7.3%
H
6.0
7
|
L
 -8.8%
H
6.0
7.3
|
L
 -3.8%
H
5.6
7.8
|
L
 53%
H
3.4
15.4
|
L
 74.9%
H
3.4
15.4
|
L
 74.9%
H
3.4
15.4
|
L
 74.9%
H
3.4
15.4
|
| Pomdoctor ADR |
|
7.8
|
1.1
|
L
 11.7%
H
0.9
1.2
|
L
 2.9%
H
0.8
1.2
|
L
 -7.1%
H
0.5
1.2
|
L
 -50.5%
H
0.5
2.5
|
L
 -98.6%
H
0.5
115.7
|
L
 -98.6%
H
0.5
115.7
|
L
 -98.6%
H
0.5
115.7
|
L
 -98.6%
H
0.5
115.7
|
| Medline Inc Ordinary Shares |
|
29,751.0
|
33.9
|
L
 -0.6%
H
33.7
34.9
|
L
 -3.2%
H
33.7
36.2
|
L
 -14.8%
H
33.1
42.2
|
L
 -5.9%
H
32.8
43.6
|
L
 -17.3%
H
32.8
50.9
|
L
 -17.3%
H
32.8
50.9
|
L
 -17.3%
H
32.8
50.9
|
L
 -17.3%
H
32.8
50.9
|
| MiniMed Group Inc |
|
5,678.6
|
20.2
|
L
 4.4%
H
19.4
20.3
|
L
 2.2%
H
19.2
20.9
|
L
 19.4%
H
16.0
20.9
|
L
 85.9%
H
10.7
20.9
|
L
H
10.7
20.9
|
L
H
10.7
20.9
|
L
H
10.7
20.9
|
L
H
10.7
20.9
|
| Mobia Medical Inc |
|
379.7
|
11.4
|
L
 -2.6%
H
11.3
12.4
|
L
 -9.2%
H
11.3
13.5
|
L
 -6.0%
H
10.3
13.9
|
L
 -7.7%
H
10.3
15.3
|
L
 -2.8%
H
10.3
15.3
|
L
 -2.8%
H
10.3
15.3
|
L
 -2.8%
H
10.3
15.3
|
L
 -2.8%
H
10.3
15.3
|
| FocalTherics ADR |
|
200.2
|
4.4
|
L
 2.4%
H
4.2
4.5
|
L
 -27.5%
H
4.1
5.0
|
L
 -19.9%
H
4.1
6.4
|
L
 -4.4%
H
4.1
6.4
|
L
 -4.4%
H
4.1
6.4
|
L
 -4.4%
H
4.1
6.4
|
L
 -4.4%
H
4.1
6.4
|
L
 -4.4%
H
4.1
6.4
|